Atara Biotherapeutics, Inc. $302 Million Follow-On Offerings

Ambrogio Visconti

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with two SEC-registered follow-on offerings of common stock of Atara Biotherapeutics,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now